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Introduction 
Composite biomaterials have enormous potential for natural bone tissue 
reparation, filling and augmentation. Composite biomaterials used today are 
available in the form of blocks, thin layers, paste, gels, powder, etc. The 
powder or injectable paste, which may play different roles when applied in 
an organism, have been used for fixing various damage in maxillofacial 
surgery, but also for filling up cavities in hard and soft tissues [1-3]. 
The aim of the study
This paper investigates possibilities of synthesizing calciumphosphate/poly- 
DL-lactide-co-glycolide (BCP/DLPLG) composite biomaterial formed as 
powder suitable for preparing injectable gels or pastes. BCP/DLPLG 
composite biomaterial was produced in form of spherical nanogranules of 
nanosized BCP covered by a DLPLG layer.
Materials and methods 
A calcium phosphate gel was produced by precipitation [1, 2]. Gels of 
calcium phosphate were added into completely dissolved polymer [3]. 
Composite biomaterials were characterized by wide-angle X-ray structural 
analysis WAXS (Enraf Nonius FR590), differential scanning calorimetry 
DSC (DSC-50 SHIMADZU), atomic force microscopy AFM (Thermo 
Microscopes, Autoprobe CP Research) and FT-IR spectroscopy (Avatar 370 
FTIR Thermo Nicolet). 
Results and discussion
As evident from Fig. 1, the obtained calcium phosphate powder is highly 
crystalline. The most intense peaks at 2θ
 
= 31.8, 32.9, 25.9 and 46.7 o originate 
from calcium hydroxyapatite (HAp) and those at 2θ
 
= 31, 34.3 and 27.8o from 
calcium phosphate (β-TCP). Based on earlier described methodology, mass 
contents of HAp and β-TCP of 80% and 20%, respectively, were calculated. 
According to DSC analysis (Fig 2.), all transformations occurring in the 
temperature range from 20 to 130 oC are connected with DLPLG. The only 
transformation is characterized by a peak at the glass transition temperature 
of 57 oC. These results indicate that DLPLG is completely amorphous 
polymer. 
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Figure 3 shows the topology of the surface of BCP/DLPLG composite 
biomaterial. Each nanoparticle of BCP was coated with DLPLG and the 
average particle diameter was between 40 and 60 nm. The nanospherical 
form of BCP/DLPLG enabled synthesis of an injectable paste, which can 
be successfully used in reconstruction of small bone damages. 
Nanoparticles may have advantages at adhesion, adsorption and 
interaction with cells.
Fig.  1. XRD patterns of BCP/DLPLG                   Fig 2. DSC of BCP/DLPLG 
composite biomaterial                         composite biomaterial
Conclusion
BCP/DLPLG composite biomaterial was synthesized in 
nanospherical form. Nanospherical particles were 40-60 nm 
in diameter, and each BCP particle was coated with 
amorphous DLPLG polymer. Calcium phosphate present in 
the composite was in the form of biphasic calcium phosphate 
consisting of 80% calcium hydroxyapatite and 20% 
tricalciumphosphate.
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Fig.  3. AFM topology of the 
surface of BCP/DLPLG 
composite biomaterial
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Figure 4. FT-IR spectrum  of 
BCP/DLPLG composite biomaterial.
After dissociating  BCPDLPLG, 
we obtained two phases: spectrum of 
DLPLG and spectrum of BCP.
